Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Myocet

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Many therapeutically active molecules are non-soluble in aqueous systems, chemically and biologically fragile or present severe… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PurposeLiposomal encapsulation of doxorubicin is designed to increase safety and tolerability by decreasing cardiac and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 5
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To ascertain the efficacy and tolerability of non-pegylated liposomal doxorubicin (Myocet) and epirubicin combined with… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Myocet (TLC D-99) is a liposomal formulation of the anti-neoplastic drug doxorubicin with an improved therapeutic index compared… Expand
Is this relevant?
Review
2003
Review
2003
Many attempts have been made to achieve good selectivity to targeted tumor cells by preparing specialized carrier agents that are… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
Review
2002
Review
2002
Doxorubicin, either as a single agent or in combination regimens, is considered to be one of the most active chemotherapeutic… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND The objective of this study was to compare the efficacy and toxicity of the liposome-encapsulated doxorubicin, TLC D… Expand
Is this relevant?
2001
2001
Summary Liposomes are phospholipid membrane vesicles that can act as carriers for drugsin order to target them to specific… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE To determine whether Myocet (liposome-encapsulated doxorubicin; The Liposome Company, Elan Corporation, Princeton, NJ) in… Expand
Is this relevant?
Review
2001
Review
2001
The anthracycline antibiotic doxorubicin has wide activity against a number of human neoplasms and is used extensively both as a… Expand
Is this relevant?